Ultragenyx Pharmaceutical | DEBITO



Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Insmed USD 1.13B 147.86M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
MacroGenics USD 0 0 2024-09
Moderna USD 62M 593M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.39B 389K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Sarepta Therapeutics USD 1.14B 90.44M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Ultragenyx Pharmaceutical DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.